←
Roger Chen ::336 posts
Roger Chen :: avatar

Roger Chen ::

@rgrchen

cofounder @onyxbio

◷ Joined June 2013▧ 24 Photos and videos
Roger Chen :: avatar
Roger Chen ::@rgrchen·Oct 8

Excited to introduce Onyx and announce our $8M seed round led by Dimension to build a virtual immune system! Onyx has always been a story of connection. The first connection was to my cofounder @amlakhan, a deeply curious technologist who I’ve been fortunate to call a friend for 19 years now. I've always said that working together was a cornerstone of starting Onyx, and it truly has been one of the best decisions I've ever made. Connection is also at the heart of what Onyx does. We believe AI is key to making biological complexity tractable, ultimately transforming life sciences into an engineering discipline. But that requires the right data. AI performance compounds with context, and richer biological context comes from more connected data. In biology, such context is often missing: molecular data, clinical history, and change over time are typically captured in isolated fragments. Onyx provides the substrate that connects them, pairing genomics, transcriptomics, proteomics, and metabolomics with rich clinical histories. By studying these layers together in people over time, our data platform traces how real human biology changes in response to infection, inflammation, and treatment. Seeing how these trajectories differ across people brings us closer to understanding what drives disease—and to developing precision medicines that work better for real people. Yet connecting data is only possible because of the people who have connected with our mission. Nearly a thousand members have already joined our research studies. They are more than research participants: they are difference-makers transforming how we understand some of humanity’s most complex and chronic diseases. I always say that our work is for people, but the truth is that people make our work possible. That connection comes full circle, and at Onyx, people will always come first. Finally, as we raised our oversubscribed round, we sought more than just business partners. We wanted investors we felt a true connection to—not merely sources of capital, but co-conspirators in creating meaningful change. To that end, we feel incredibly fortunate to have joined forces with @_DimensionCap, @haystackvc, @refactor, @standard_vc, @robotventures, and many more. Now back to building!

Onyx@onyxbioOct 8

Today we're introducing Onyx, a research collective building a virtual immune system: a model of how real people respond to infection, inflammation, and treatment. We're launching with an $8M seed round led by Dimension Capital. onyx.bio/news/introducing-on…

Alok Vasudev avatar
⟳ Roger Chen :: retweeted
Alok Vasudev@AlokVasudev·Oct 8

Onyx AI will learn to reason about bio and medicine, yes. That will come from startups creatively assembling new multidisciplinary datasets paid for by AI labs and pharma, yes. But a great dataset alone does not manifest a great company. That requires a unique point of view on terminal value. Onyx has that and it stems from a question not frequently asked in AI x Bio: What role does the patient play here exactly? The Onyx approach takes inspiration from its roots in experimental science, real world ML, cryptography, and internet community stewardship. On a personal note - Roger has been a close collaborator and dear friend dating back to our days as PhD students (even though he went to Berkeley, a shit school). Humans like Roger and Amit are who we want shepherding us into this brave new world. We're thrilled to be a part of the adventure.

Excited to introduce Onyx and announce our $8M seed round led by Dimension to build a virtual immune system! Onyx has always been a story of connection. The first connection was to my cofounder @amlakhan, a deeply curious technologist who I’ve been fortunate to call a friend for 19 years now. I've always said that working together was a cornerstone of starting Onyx, and it truly has been one of the best decisions I've ever made. Connection is also at the heart of what Onyx does. We believe AI is key to making biological complexity tractable, ultimately transforming life sciences into an engineering discipline. But that requires the right data. AI performance compounds with context, and richer biological context comes from more connected data. In biology, such context is often missing: molecular data, clinical history, and change over time are typically captured in isolated fragments. Onyx provides the substrate that connects them, pairing genomics, transcriptomics, proteomics, and metabolomics with rich clinical histories. By studying these layers together in people over time, our data platform traces how real human biology changes in response to infection, inflammation, and treatment. Seeing how these trajectories differ across people brings us closer to understanding what drives disease—and to developing precision medicines that work better for real people. Yet connecting data is only possible because of the people who have connected with our mission. Nearly a thousand members have already joined our research studies. They are more than research participants: they are difference-makers transforming how we understand some of humanity’s most complex and chronic diseases. I always say that our work is for people, but the truth is that people make our work possible. That connection comes full circle, and at Onyx, people will always come first. Finally, as we raised our oversubscribed round, we sought more than just business partners. We wanted investors we felt a true connection to—not merely sources of capital, but co-conspirators in creating meaningful change. To that end, we feel incredibly fortunate to have joined forces with @_DimensionCap, @haystackvc, @refactor, @standard_vc, @robotventures, and many more. Now back to building!

Amit Lakhani avatar
⟳ Roger Chen :: retweeted
Amit Lakhani@amlakhan·Oct 8

@rgrchen and I started @onyxbio to understand how real immune systems evolve in real people. By generating multiomic datasets from our members over time, we aim to help cross the trial failure chasm. Shoutout to @_DimensionCap @haystackvc @refactor and more for believing in us!

Onyx@onyxbioOct 8

Today we're introducing Onyx, a research collective building a virtual immune system: a model of how real people respond to infection, inflammation, and treatment. We're launching with an $8M seed round led by Dimension Capital. onyx.bio/news/introducing-on…

Nan Li avatar
⟳ Roger Chen :: retweeted
Nan Li@nanli·Oct 8

Excited to announce our partnership with @rgrchen, @amlakhan and the team at @onyxbio! We believe that precision immunology is one of the most interesting directions of new medicines and that multi-modal, longitudinal datasets from real patients are needed to power this field. Onyx is building a unified data platform for immunology - combining clinical records, multi-omics, sample banking, and patient reported outcomes. This platform helps researchers to understand how immune diseases progress, why patients respond differently to treatment, and uncover new ideas for medicines. At the limit, these data will power the buildout of a entirely virtual immune model to simulate human immunology with high precision. We have known Roger for over a decade and are excited to reunite! Nearly a thousand patients are already enrolled onto the platform and looking forward to much more to come! onyx.bio/

Post attachment
Nick Soman avatar
⟳ Roger Chen :: retweeted
Nick Soman@nicksoman·Oct 5

Your health plan should get better year-round. Not just once a year. Today we're launching @Decent on @ycombinator. We find the best health plan for your company, then keep making it better all year.

0:42
Tarun Chitra avatar
⟳ Roger Chen :: retweeted
Tarun Chitra@tarunchitra·Aug 17

Every successful marketplace has winners and losers But some participants make it more of a dark forest than a chessboard We find some direct evidence for this — and some simple math to make these marketplaces more robust to rogue inference providers!

Adam Goulburn avatar
⟳ Roger Chen :: retweeted
Adam Goulburn@AGoulburn·Jul 21

Announcing Dimension III An $800M fund to team with the world’s most ambitious entrepreneurs pioneering the frontiers of science and compute Pumped to continue to partner with our existing and future founders!

DIMENSION @_DimensionCap Jul 21 Article Dimension III: a $800M fund to invest across the frontiers of science and compute Don't be encumbered by history - go off and do something wonderful (Robert Noyce) To our current and future Founders: Today we write to announce the launch of Dimension III, a $800M fund to invest

Zavain Dar avatar
⟳ Roger Chen :: retweeted
Zavain Dar@zavaindar·Jul 21

Today we're unveiling Dimension III: a $800M fund to partner with the leading entrepreneurs across the frontiers of compute (silicon through infrastructure) & science (biotech through physics). To our founders, past, present, and future: now is your time. LFG!

Post attachmentPost attachmentPost attachment
Nan Li avatar
⟳ Roger Chen :: retweeted
Nan Li@nanli·Jul 21

Thrilled to announce Dimension III, a fresh $800M fund which takes the firm up to $1.6B AUM. Even since we launched the firm a few years ago, the overlapping exponential curves of science, AI, infrastructure, and hardware have continued to scale at staggering rates. We are more certain than ever that a research-led, long-term oriented investment practice is the right capital partner to ambitious founders in this era. If you are building something technically ambitious and possibly a little crazy, you are in good company here. While the fund, our team, and our ambitions continue to grow, we remain steadfast on our mission to partner with founders building at the frontiers of science and compute. Excited for the future ahead, let’s go build it!

DIMENSION @_DimensionCap Jul 21 Article Dimension III: a $800M fund to invest across the frontiers of science and compute Don't be encumbered by history - go off and do something wonderful (Robert Noyce) To our current and future Founders: Today we write to announce the launch of Dimension III, a $800M fund to invest

Soups Ranjan avatar
⟳ Roger Chen :: retweeted
Soups Ranjan@soupsranjan·11 Feb 2025

Today we're announcing Sardine's $70M Series C 🚀 Money moves at the speed of light. Crime moves at the speed of AI. Between these forces, trust is eroding faster than ever. We built Sardine to move faster than the threat - and it's working.

Post attachment